Skip to content
Compounder
← Stocks

Labcorp Holdings Inc

LHAbove value

Held by 4 superinvestors.

Price$335.72
Holders4
Total value$128.8M

SEC 10-K · fundamentals

Business quality

as of 2025-12-31

Valuation basis: trailing twelve months to 2026-06-30 — latest 10-K plus unaudited 10-Q filings.

Revenue growth
+7.2%
Net margin
6.3%
ROE
10.2%
FCF margin
8.6%
Revenue $13.98B → $13.95B · 6y
What makes a business high quality

Valuation · value band

Above fair value

$147/ sh · growth-anchored intrinsic value
margin of safety
fair value
above fair value
$336
cheaperpricier

Zero-growth floor

$104

Central IV

$147

Optimistic top

$171

Labcorp Holdings Inc (LH): A conservative value band $104–$171 / sh (zero-growth floor to growth-capped optimistic top); central read about $147. Today’s price sits above that band (price $336 as of 2026-08-26).

The middle figure is the main read. The right end is the optimistic case under the same conservative caps — not an absolute ceiling.

  • Recent earnings are below the multi-year average, so the band uses the lower run-rate.

Revenue growth 0% (history declining, capped at zero) · moat 10 yr · discount 11.2% · Zero-growth downside $104

Price as of 2026-08-26 · yahoo · DGS10 4.7% @ 2026-08-26.

Method & numbers

A conservative intrinsic-value band (zero-growth floor to growth-capped DCF) plus a tangible asset floor — not investment advice, not a buy/sell signal, and not a price target.

Owner-earnings DCF $130.65 – $168.61 · Greenwald zero-growth $171.41 · zero-growth base $171.41 · reproduction $39.67

Moat Franchise (moat) · terminal value 35% of present value · owner-earnings yield 5% vs 10Y 4.7%.

Graham earnings-power value (normalized NOPAT)$104.18 – $142.83 / sh

Normalized NOPAT = average operating margin over the years shown × latest-year revenue × (1 − normalized tax); then + D&A − maintenance capex (write A). Unlevered (pre-interest, attributable to all capital). Capitalized at the 9–11% rate band (read as a WACC proxy). Enterprise → equity bridge applied: + cash − total debt.

Years: TTM 2026-06-30, 2024, 2023, 2022, 2021

v1 simplifications: Maintenance capex (degraded) deducted in full cash (write A): EPV = (NOPAT + D&A − maintenance capex) / WACC; no tax shield on the capex term. Maintenance-capex methods diverge by 162% (> 50%); estimate is degraded. Share-based compensation is left as a real expense (not added back). Operating margin is below its multi-year average (cyclical/declining): normalized margin capped at the latest year — no peak-margin capitalization (audit #2).

Buffett owner-earnings value$141.90 – $171.41 / sh

Owner earnings = average net income + average D&A − maintenance capex (zero-growth floor; no ΔNWC). Levered (starts from net income, already after interest — an equity-holder stream). Capitalized at the 9.6–11.6% band (9–11% base + 0.6pp leverage premium). No enterprise→equity bridge: the capitalized result is already equity value (subtracting debt would double-count interest).

Years: TTM 2026-06-30, 2024, 2023, 2022, 2021

v1 simplifications: Net income is below its multi-year average (cyclical/declining): normalized owner earnings anchored to the latest year — no peak-earnings capitalization (audit #2). Owner earnings = net income + D&A − maintenance capex (degraded); the working-capital change is excluded (maintenance ΔNWC ≈ 0; growth ΔNWC is carried in growth value, not double-counted). Maintenance-capex methods diverge by 162% (> 50%); estimate is degraded. One-time items are not separately normalized (multi-year averaging smooths them partially). Share-based compensation is left as a real expense (not added back); see the SBC/OE disclosure. Capitalized at the 9–11% base band plus a 0.6pp leverage premium (cost of equity rises with leverage — MM Proposition II). Net debt is about 4.2 years of owner earnings, adding 0.6pp of cost-of-equity risk premium.

Asset floor: Reproduction value = tangible net assets + acquired-intangible reset proxy, ÷ diluted shares; tangible net assets alone are negative for this asset-light franchise (no R&D history to capitalize).

Moat reading: Franchise test compares earnings power (EPV) against reproduction value (tangible net assets + capitalized R&D). EPV well above reproduction value signals a moat; near it, a commodity; below it, value destruction. A directional reading, not a verdict.

Assumes a narrow moat · competitive-advantage period ≈ 10 years.

Growth value not assessable — No positive growth reinvestment in the matured window, so ROIIC cannot be computed.

Window TTM 2026-06-30, FY 2024, 2023, 2022, 2021 · discount band 9%–11% · normalized tax 21% (No effective-rate data available; fell back to the statutory 21%.) · diluted shares.

Baseline 9%–11%, net debt ≈ 4.2 years of owner earnings → +0.6pp cost-of-equity premium → effective 9.6%–11.6%.

Owner-earnings DCF: growth g₁ 0% (history declining → capped at 0) · OE FY TTM 2026-06-30, 2024, 2023, 2022, 2021 · Discount band: 9.77%–12.61% (DGS10 +4.5% to a 12% strict end, each +0.61pp for leverage premium, as of 2026-08-26). No enterprise→equity bridge: owner earnings already flow to shareholders (post-interest), so no net cash is added and no debt subtracted — matching the engine owner-earnings lamp.

Valuation basis: trailing twelve months to 2026-06-30 — latest 10-K plus unaudited 10-Q filings.

How to read intrinsic value

SEC 13F · holders

Superinvestors Holding This Security

4 holders · $128.8M combined · this quarter +0 opened / -1 exited

This quarter3 trimmed1 exited
Holders 4 → 4 · last 8q
  • John Rogers
    Value$97.8MWeight (prev→now)1.1% → 1.0% ▼
  • Wallace Weitz
    Value$27.7MWeight (prev→now)1.8% → 1.9% ▲
  • Paul Lountzis
    Value$2.5MWeight (prev→now)0.9% → 0.8% ▼
  • Ray Dalio
    Value$783,440Weight (prev→now)0.0% → 0.0% ▼
Exited this quarter (1)
Lee Ainslie

SEC 13F · notes

Written summary

Labcorp Holdings Inc (LH) is held by 4 of the superinvestors tracked on Compounder, with a combined $128.8M in reported 13F value. The largest position belongs to John Rogers, where it makes up 1.0% of the portfolio.

Other notable holders by value include Wallace Weitz (1.9% of its book), Paul Lountzis (0.8% of its book) and Ray Dalio (0.0% of its book).

Over the latest quarter, 0 of the tracked filers opened a new position in LH, 0 added to existing ones, 3 trimmed, and 1 sold out entirely.

Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.

How to read a 13F

SEC 13F · co-ownership

Also held by these investors

Investors holding Labcorp Holdings Inc (LH) also commonly hold →

See which stocks look cheap against a conservative value band. Browse all valued stocks

Also on

Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-14

Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.

Stay Updated

New-quarter 13F moves and valuation updates, to your inbox.